Phosphoglycan beta 1,3 galactosyltransferase (required for proper protective coat formation). Probably part of a much larger group. Expanded in Leishmaniids. Localization: Golgi (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 16 |
NetGPI | no | yes: 0, no: 16 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 17 |
GO:0110165 | cellular anatomical entity | 1 | 17 |
GO:0000139 | Golgi membrane | 5 | 3 |
GO:0031090 | organelle membrane | 3 | 3 |
GO:0098588 | bounding membrane of organelle | 4 | 3 |
Related structures:
AlphaFold database: A4H3B5
Term | Name | Level | Count |
---|---|---|---|
GO:0006486 | protein glycosylation | 4 | 17 |
GO:0006807 | nitrogen compound metabolic process | 2 | 17 |
GO:0008152 | metabolic process | 1 | 17 |
GO:0019538 | protein metabolic process | 3 | 17 |
GO:0036211 | protein modification process | 4 | 17 |
GO:0043170 | macromolecule metabolic process | 3 | 17 |
GO:0043412 | macromolecule modification | 4 | 17 |
GO:0043413 | macromolecule glycosylation | 3 | 17 |
GO:0044238 | primary metabolic process | 2 | 17 |
GO:0070085 | glycosylation | 2 | 17 |
GO:0071704 | organic substance metabolic process | 2 | 17 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 17 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 17 |
GO:0016740 | transferase activity | 2 | 17 |
GO:0016757 | glycosyltransferase activity | 3 | 17 |
GO:0016758 | hexosyltransferase activity | 4 | 17 |
GO:0008194 | UDP-glycosyltransferase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 116 | 118 | PF00675 | 0.736 |
CLV_NRD_NRD_1 | 121 | 123 | PF00675 | 0.667 |
CLV_NRD_NRD_1 | 18 | 20 | PF00675 | 0.416 |
CLV_NRD_NRD_1 | 200 | 202 | PF00675 | 0.564 |
CLV_NRD_NRD_1 | 30 | 32 | PF00675 | 0.489 |
CLV_NRD_NRD_1 | 373 | 375 | PF00675 | 0.384 |
CLV_NRD_NRD_1 | 442 | 444 | PF00675 | 0.385 |
CLV_NRD_NRD_1 | 460 | 462 | PF00675 | 0.384 |
CLV_PCSK_KEX2_1 | 116 | 118 | PF00082 | 0.731 |
CLV_PCSK_KEX2_1 | 121 | 123 | PF00082 | 0.663 |
CLV_PCSK_KEX2_1 | 200 | 202 | PF00082 | 0.535 |
CLV_PCSK_KEX2_1 | 30 | 32 | PF00082 | 0.514 |
CLV_PCSK_KEX2_1 | 373 | 375 | PF00082 | 0.427 |
CLV_PCSK_KEX2_1 | 441 | 443 | PF00082 | 0.461 |
CLV_PCSK_KEX2_1 | 460 | 462 | PF00082 | 0.423 |
CLV_PCSK_KEX2_1 | 483 | 485 | PF00082 | 0.489 |
CLV_PCSK_PC1ET2_1 | 441 | 443 | PF00082 | 0.461 |
CLV_PCSK_PC1ET2_1 | 483 | 485 | PF00082 | 0.424 |
CLV_PCSK_PC7_1 | 117 | 123 | PF00082 | 0.562 |
CLV_PCSK_PC7_1 | 369 | 375 | PF00082 | 0.367 |
CLV_PCSK_SKI1_1 | 11 | 15 | PF00082 | 0.505 |
CLV_PCSK_SKI1_1 | 117 | 121 | PF00082 | 0.637 |
CLV_PCSK_SKI1_1 | 189 | 193 | PF00082 | 0.331 |
CLV_PCSK_SKI1_1 | 225 | 229 | PF00082 | 0.430 |
CLV_PCSK_SKI1_1 | 480 | 484 | PF00082 | 0.392 |
CLV_PCSK_SKI1_1 | 63 | 67 | PF00082 | 0.502 |
DEG_SCF_FBW7_1 | 161 | 168 | PF00400 | 0.694 |
DOC_CKS1_1 | 162 | 167 | PF01111 | 0.700 |
DOC_CYCLIN_yCln2_LP_2 | 159 | 165 | PF00134 | 0.675 |
DOC_MAPK_MEF2A_6 | 189 | 196 | PF00069 | 0.624 |
DOC_MAPK_MEF2A_6 | 328 | 337 | PF00069 | 0.400 |
DOC_PP1_RVXF_1 | 187 | 194 | PF00149 | 0.489 |
DOC_PP1_RVXF_1 | 223 | 230 | PF00149 | 0.516 |
DOC_PP1_RVXF_1 | 381 | 387 | PF00149 | 0.312 |
DOC_PP2B_LxvP_1 | 159 | 162 | PF13499 | 0.676 |
DOC_PP4_FxxP_1 | 167 | 170 | PF00568 | 0.631 |
DOC_USP7_MATH_1 | 280 | 284 | PF00917 | 0.490 |
DOC_USP7_MATH_1 | 462 | 466 | PF00917 | 0.372 |
DOC_WW_Pin1_4 | 128 | 133 | PF00397 | 0.718 |
DOC_WW_Pin1_4 | 161 | 166 | PF00397 | 0.625 |
DOC_WW_Pin1_4 | 413 | 418 | PF00397 | 0.431 |
DOC_WW_Pin1_4 | 482 | 487 | PF00397 | 0.416 |
DOC_WW_Pin1_4 | 74 | 79 | PF00397 | 0.529 |
LIG_14-3-3_CanoR_1 | 122 | 132 | PF00244 | 0.561 |
LIG_14-3-3_CanoR_1 | 19 | 23 | PF00244 | 0.423 |
LIG_14-3-3_CanoR_1 | 282 | 286 | PF00244 | 0.462 |
LIG_14-3-3_CanoR_1 | 350 | 356 | PF00244 | 0.450 |
LIG_14-3-3_CanoR_1 | 369 | 373 | PF00244 | 0.324 |
LIG_14-3-3_CanoR_1 | 63 | 68 | PF00244 | 0.550 |
LIG_Actin_WH2_2 | 359 | 375 | PF00022 | 0.324 |
LIG_BIR_III_2 | 471 | 475 | PF00653 | 0.351 |
LIG_BRCT_BRCA1_1 | 75 | 79 | PF00533 | 0.528 |
LIG_Clathr_ClatBox_1 | 313 | 317 | PF01394 | 0.238 |
LIG_CtBP_PxDLS_1 | 53 | 57 | PF00389 | 0.488 |
LIG_eIF4E_1 | 308 | 314 | PF01652 | 0.250 |
LIG_FHA_1 | 147 | 153 | PF00498 | 0.625 |
LIG_FHA_1 | 34 | 40 | PF00498 | 0.415 |
LIG_FHA_1 | 80 | 86 | PF00498 | 0.546 |
LIG_FHA_2 | 102 | 108 | PF00498 | 0.488 |
LIG_FHA_2 | 340 | 346 | PF00498 | 0.327 |
LIG_LIR_Apic_2 | 164 | 170 | PF02991 | 0.611 |
LIG_LIR_Apic_2 | 212 | 217 | PF02991 | 0.579 |
LIG_LIR_Gen_1 | 248 | 258 | PF02991 | 0.337 |
LIG_LIR_Gen_1 | 349 | 357 | PF02991 | 0.406 |
LIG_LIR_Gen_1 | 400 | 410 | PF02991 | 0.613 |
LIG_LIR_Gen_1 | 430 | 436 | PF02991 | 0.368 |
LIG_LIR_Nem_3 | 21 | 25 | PF02991 | 0.548 |
LIG_LIR_Nem_3 | 248 | 254 | PF02991 | 0.309 |
LIG_LIR_Nem_3 | 349 | 355 | PF02991 | 0.417 |
LIG_LIR_Nem_3 | 400 | 405 | PF02991 | 0.655 |
LIG_LIR_Nem_3 | 406 | 410 | PF02991 | 0.446 |
LIG_LIR_Nem_3 | 430 | 435 | PF02991 | 0.434 |
LIG_NRBOX | 315 | 321 | PF00104 | 0.272 |
LIG_NRBOX | 362 | 368 | PF00104 | 0.323 |
LIG_REV1ctd_RIR_1 | 424 | 433 | PF16727 | 0.338 |
LIG_SH2_CRK | 251 | 255 | PF00017 | 0.487 |
LIG_SH2_CRK | 432 | 436 | PF00017 | 0.378 |
LIG_SH2_NCK_1 | 488 | 492 | PF00017 | 0.381 |
LIG_SH2_NCK_1 | 92 | 96 | PF00017 | 0.582 |
LIG_SH2_SRC | 232 | 235 | PF00017 | 0.507 |
LIG_SH2_SRC | 25 | 28 | PF00017 | 0.462 |
LIG_SH2_SRC | 422 | 425 | PF00017 | 0.324 |
LIG_SH2_STAP1 | 232 | 236 | PF00017 | 0.598 |
LIG_SH2_STAP1 | 432 | 436 | PF00017 | 0.377 |
LIG_SH2_STAT5 | 154 | 157 | PF00017 | 0.566 |
LIG_SH2_STAT5 | 173 | 176 | PF00017 | 0.395 |
LIG_SH2_STAT5 | 263 | 266 | PF00017 | 0.446 |
LIG_SH2_STAT5 | 422 | 425 | PF00017 | 0.539 |
LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.388 |
LIG_SH3_3 | 127 | 133 | PF00018 | 0.580 |
LIG_SH3_3 | 159 | 165 | PF00018 | 0.675 |
LIG_SH3_3 | 269 | 275 | PF00018 | 0.379 |
LIG_SH3_3 | 321 | 327 | PF00018 | 0.358 |
LIG_SH3_3 | 47 | 53 | PF00018 | 0.390 |
LIG_SH3_3 | 504 | 510 | PF00018 | 0.352 |
LIG_SH3_5 | 417 | 421 | PF00018 | 0.255 |
LIG_SUMO_SIM_par_1 | 52 | 60 | PF11976 | 0.489 |
LIG_TRAF2_1 | 24 | 27 | PF00917 | 0.570 |
LIG_TYR_ITIM | 23 | 28 | PF00017 | 0.556 |
MOD_CAAXbox | 523 | 526 | PF01239 | 0.335 |
MOD_CK1_1 | 141 | 147 | PF00069 | 0.589 |
MOD_CK1_1 | 150 | 156 | PF00069 | 0.467 |
MOD_CK2_1 | 166 | 172 | PF00069 | 0.631 |
MOD_CK2_1 | 85 | 91 | PF00069 | 0.662 |
MOD_Cter_Amidation | 439 | 442 | PF01082 | 0.389 |
MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.470 |
MOD_GlcNHglycan | 140 | 143 | PF01048 | 0.490 |
MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.568 |
MOD_GlcNHglycan | 155 | 158 | PF01048 | 0.552 |
MOD_GlcNHglycan | 178 | 181 | PF01048 | 0.592 |
MOD_GlcNHglycan | 309 | 312 | PF01048 | 0.271 |
MOD_GlcNHglycan | 437 | 440 | PF01048 | 0.423 |
MOD_GlcNHglycan | 63 | 66 | PF01048 | 0.571 |
MOD_GSK3_1 | 137 | 144 | PF00069 | 0.612 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.577 |
MOD_GSK3_1 | 157 | 164 | PF00069 | 0.558 |
MOD_GSK3_1 | 431 | 438 | PF00069 | 0.364 |
MOD_GSK3_1 | 55 | 62 | PF00069 | 0.698 |
MOD_GSK3_1 | 98 | 105 | PF00069 | 0.476 |
MOD_N-GLC_1 | 102 | 107 | PF02516 | 0.483 |
MOD_N-GLC_1 | 280 | 285 | PF02516 | 0.489 |
MOD_N-GLC_1 | 73 | 78 | PF02516 | 0.620 |
MOD_NEK2_1 | 138 | 143 | PF00069 | 0.495 |
MOD_NEK2_1 | 435 | 440 | PF00069 | 0.419 |
MOD_NEK2_1 | 79 | 84 | PF00069 | 0.480 |
MOD_NEK2_2 | 296 | 301 | PF00069 | 0.333 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.312 |
MOD_PIKK_1 | 220 | 226 | PF00454 | 0.535 |
MOD_PKA_1 | 200 | 206 | PF00069 | 0.589 |
MOD_PKA_2 | 138 | 144 | PF00069 | 0.635 |
MOD_PKA_2 | 18 | 24 | PF00069 | 0.470 |
MOD_PKA_2 | 200 | 206 | PF00069 | 0.601 |
MOD_PKA_2 | 281 | 287 | PF00069 | 0.456 |
MOD_PKA_2 | 368 | 374 | PF00069 | 0.317 |
MOD_Plk_1 | 247 | 253 | PF00069 | 0.341 |
MOD_Plk_1 | 280 | 286 | PF00069 | 0.448 |
MOD_Plk_1 | 403 | 409 | PF00069 | 0.433 |
MOD_Plk_2-3 | 55 | 61 | PF00069 | 0.554 |
MOD_Plk_4 | 150 | 156 | PF00069 | 0.521 |
MOD_Plk_4 | 18 | 24 | PF00069 | 0.419 |
MOD_Plk_4 | 247 | 253 | PF00069 | 0.341 |
MOD_Plk_4 | 406 | 412 | PF00069 | 0.552 |
MOD_ProDKin_1 | 128 | 134 | PF00069 | 0.711 |
MOD_ProDKin_1 | 161 | 167 | PF00069 | 0.635 |
MOD_ProDKin_1 | 413 | 419 | PF00069 | 0.429 |
MOD_ProDKin_1 | 482 | 488 | PF00069 | 0.412 |
MOD_ProDKin_1 | 74 | 80 | PF00069 | 0.526 |
TRG_DiLeu_BaLyEn_6 | 315 | 320 | PF01217 | 0.353 |
TRG_ENDOCYTIC_2 | 234 | 237 | PF00928 | 0.493 |
TRG_ENDOCYTIC_2 | 25 | 28 | PF00928 | 0.550 |
TRG_ENDOCYTIC_2 | 251 | 254 | PF00928 | 0.469 |
TRG_ENDOCYTIC_2 | 352 | 355 | PF00928 | 0.506 |
TRG_ENDOCYTIC_2 | 402 | 405 | PF00928 | 0.487 |
TRG_ENDOCYTIC_2 | 432 | 435 | PF00928 | 0.394 |
TRG_ER_diArg_1 | 115 | 117 | PF00400 | 0.750 |
TRG_ER_diArg_1 | 120 | 122 | PF00400 | 0.649 |
TRG_ER_diArg_1 | 200 | 202 | PF00400 | 0.535 |
TRG_ER_diArg_1 | 372 | 374 | PF00400 | 0.416 |
TRG_NLS_MonoExtC_3 | 204 | 210 | PF00514 | 0.407 |
TRG_NLS_MonoExtN_4 | 202 | 209 | PF00514 | 0.417 |
TRG_Pf-PMV_PEXEL_1 | 206 | 210 | PF00026 | 0.507 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A451EJF6 | Leishmania donovani | 51% | 80% |
A0A451EJF8 | Leishmania donovani | 53% | 68% |
A4H3A9 | Leishmania braziliensis | 94% | 100% |
A4H3B6 | Leishmania braziliensis | 92% | 73% |
A4HNK3 | Leishmania braziliensis | 41% | 89% |
A4HNK6 | Leishmania braziliensis | 41% | 66% |
A4HRM0 | Leishmania infantum | 63% | 71% |
A4HRM1 | Leishmania infantum | 51% | 80% |
A4HRS5 | Leishmania infantum | 53% | 68% |
E9AC95 | Leishmania major | 51% | 100% |
E9AI30 | Leishmania braziliensis | 37% | 100% |
E9AIP8 | Leishmania braziliensis | 41% | 67% |
E9AJI5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 55% | 68% |
E9ALD6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 41% | 71% |
V5B1J5 | Trypanosoma cruzi | 24% | 100% |